NCT03769142

Brief Summary

Arterial hypotension during general anesthesia remains a factor of poor outcomes, increases the risk of myocardial infarction, acute kidney injury and 1-year mortality. Furthermore, arterial hypotension may also decrease cerebral perfusion contributing to worsen neurological outcome. It seems necessary to monitor cerebral perfusion during anesthesia and to define individual dynamic targets of blood pressure. The goal of this study is to evaluate cerebral perfusion change in adult patients with or without cardiovascular risk factors during a standardized propofol-remifentanil anesthesia induction. Cerebral perfusion will be evaluated and compared using the simultaneously measure of TCD, NIRS and BIS. Those measures will be also repeated during and after treatment of arterial hypotension episodes in both groups.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2014

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 10, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 7, 2018

Completed
Last Updated

December 7, 2018

Status Verified

October 1, 2018

Enrollment Period

2.8 years

First QC Date

October 10, 2018

Last Update Submit

December 6, 2018

Conditions

Keywords

cerebral perfusionhypotensiontranscranial Dopplergeneral anesthesiaBispectral IndexNear-infrared spectroscopy (NIRS)

Outcome Measures

Primary Outcomes (4)

  • Continuous measure of mean arterial pressure in mmHg (MAP)

    For all patients, mean arterial pressure will be collected at three distinct periods: (1) Baseline or during pre-oxygenation at FiO2 21% in awake patients, (2) Before Orotracheal Intubation and (3) just after mechanical ventilation

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  • Measure of cerebral blood flow (CFV in cm/s) with Transcranial Doppler

    For all patients, cerebral flow velocity will be collected at three distinct periods: (1) Baseline or during pre-oxygenation at FiO2 21% in awake patients, (2) Before Orotracheal Intubation and (3) just after mechanical ventilation.

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  • Continuous measure of Burst Suppression (BS in %) with Bispectral Index (BIS)

    For all patients, Burst Supression will be collected at three distinct periods: (1) Baseline or during pre-oxygenation at FiO2 21% in awake patients, (2) Before Orotracheal Intubation and (3) just after mechanical ventilation.

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  • Continuous measure of cerebral oxygen saturation (SO2 in %) with Near-infrared spectroscopy (NIRS)

    For all patients, cerebral oxygen saturation will be collected at three distinct periods: (1) Baseline or during pre-oxygenation at FiO2 21% in awake patients, (2) Before Orotracheal Intubation and (3) just after mechanical ventilation.

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

Interventions

All monitoring (TCD, BIS, NIRS) are collected from the healthy side, contralateral to the interventional side

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with scheduled an elective interventional neuroradiology procedure requiring general anesthesia

You may qualify if:

  • patients \> 18 years, scheduled an elective interventional neuroradiology procedure requiring general anesthesia
  • oral agreement obtained from each patient before anesthesia

You may not qualify if:

  • age \<18 years
  • an emergency procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Manquat E, Ravaux H, Kindermans M, Joachim J, Serrano J, Touchard C, Mateo J, Mebazaa A, Gayat E, Vallee F, Cartailler J. Impact of impaired cerebral blood flow autoregulation on electroencephalogram signals in adults undergoing propofol anaesthesia: a pilot study. BJA Open. 2022 Mar 2;1:100004. doi: 10.1016/j.bjao.2022.100004. eCollection 2022 Mar.

MeSH Terms

Conditions

Hypotension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Joaquim MATEO, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2018

First Posted

December 7, 2018

Study Start

February 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

December 7, 2018

Record last verified: 2018-10